Inventor · disambiguated record
Sanjeevani Ghone
Also filed as: GHONE SANJEEVANI
7 granted patents·3 pending applications·46 citations·filing 2013–2024
77Inventor score
Files withTAXIS PHARMACEUTICALS INC4CELGENE CORP2CELLERANT THERAPEUTICS INC2POLYTHERICS LTD1SCIPHARM SÀRL1
Top patents by PatentIndex Score
10 records- 0194US9346738B2Process for the preparation of treprostinil and derivatives thereofSCIPHARM SÀRL·Filed 2013·Granted May 24, 2016·44 cites·17 claims
- 0283US2025257074A1Synthetic processes and synthetic intermediatesTAXIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0379US12173013B2Synthetic processes and synthetic intermediatesTAXIS PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·0 cites·16 claims
- 0472US10774093B2Synthetic processes and synthetic intermediatesTAXIS PHARMACEUTICALS INC·Filed 2018·Granted Sep 15, 2020·1 cites·12 claims
- 0571US10350218B2Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimersCELLERANT THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·1 cites·11 claims
- 0666US2021139508A1Synthetic processes and synthetic intermediatesTAXIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0755US11014940B1Thiazolidinone and oxazolidinone compounds and formulationsCELGENE CORP·Filed 2019·Granted May 25, 2021·0 cites·24 claims
- 0850US12227519B2Preparation of maytansinolCELGENE CORP·Filed 2020·Granted Feb 18, 2025·0 cites·11 claims
- 0950US2020061079A1Isoquinolidinobenzodiazepine (iqb)-1(chloromethyl)-2,3-dihydro-1h-benzo[e]indole (cbi) dimersCELLERANT THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1035US10654873B2Cytotoxic agents and conjugates thereofPOLYTHERICS LTD·Filed 2017·Granted May 19, 2020·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Sanjeevani Ghone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →